Jamie Caracciolo

Dr. Jamie Caracciolo

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2023 in Journal of the American College of Radiology
Verified
Journal Article
Closed access
JCJamie Caracciolo
Jamie Caracciolo
SASayed Ali
Sayed Ali
CCConnie Y. Chang
Connie Y. Chang
ADAndrew J. Degnan
Andrew J. Degnan
DFDonald J. Flemming
Donald J. Flemming
MMMark D. Murphey
Mark D. Murphey

1 October 2016 in Surgical Clinics of North America
Verified
Journal Article
Closed access
JCJamie Caracciolo
Jamie Caracciolo
GLG. Douglas Letson
G. Douglas Letson

6 February 2013 in Skeletal Radiology
Verified
Journal Article
Closed access
PDF file
WLWeifeng Liu
Weifeng Liu
MBMarilyn Bui
Marilyn Bui
DCDavid Cheong
David Cheong
JCJamie Caracciolo
Jamie Caracciolo

1 February 2019 in Radiology Case Reports
Verified
Journal Article
Open access
JCJamie Caracciolo
Jamie Caracciolo
EHEvita Henderson-Jackson
Evita Henderson-Jackson
OBOdion Binitie
Odion Binitie
Synovial sarcoma typically presents as periarticular soft tissue mass in adolescent and young adult patients. Very rarely, soft tissue sarcomas may arise primarily within bone posing a significant diagnostic challenge as primary osseous malignancies such as osteosarcoma and metastatic disease are much more common. While tissue sampling with immunohistochemical and genetic testing are required for definitive diagnosis, radiologists and orthopedic oncologists should consider alternate etiologies when typical imaging features of more common bone tumors are not identified. As an example, we present a 33-year-old male referred with a pathologic hip fracture proven to represent primary synovial sarcoma of bone.

3 February 2010 in Cases Journal
Verified
Journal Article
Open access
PDF file
NRNicole D Riddle
Nicole D Riddle
HYHideko Yamauchi
Hideko Yamauchi
JCJamie Caracciolo
Jamie Caracciolo
DCDavid Cheong
David Cheong
NKNazanin Khakpour
Nazanin Khakpour
MBMarilyn Bui
Marilyn Bui
Giant cell tumor (GCT) is an aggressive, but usually benign bone neoplasm most commonly arising in the metaphysis/epiphyses of long bones. While they are categorized as benign tumors, they can be locally aggressive and clinically have metastatic potential. The most common locations of this tumor include the distal femur, proximal tibia, and distal radius. We report a GCT arising in an atypical location and mimicking a breast mass. This case was diagnosed at a large cancer center in Florida. Pertinent clinical findings were obtained from chart review and inter-departmental consultation. Radiologically, the initial impression included a deep-seated breast cancer with local chest wall invasion. Further evaluation revealed the mass to be an expansile rib lesion with extraosseous soft tissue invasion. Histological examination of the biopsy specimen showed bland multi-nucleated giant cells and mononuclear cells whose nuclei were morphologically similar. No necrosis, pleomorphism or mitotic activity was identified. No chondroid or osseous elements were present. The histological features of bland mononuclear and multinucleated giant cells along with the lack of any additional mesenchymal elements led to the diagnosis of giant cell tumor. Resection of tumor was performed. The patient is disease free as of the last follow-up visit. This case is important as it shows where the physician must keep this diagnosis in mind whenever a deeply located breast mast is present.

8 April 2017 in BMC Cancer
Verified
Journal Article
Open access
PDF file
THTimothy M. Hoggard
Timothy M. Hoggard
EHEvita Henderson-Jackson
Evita Henderson-Jackson
MBMarilyn Bui
Marilyn Bui
JCJamie Caracciolo
Jamie Caracciolo
JTJamie K. Teer
Jamie K. Teer
DRDamon Reed
Damon Reed
Myoepithelial carcinoma of soft tissue is a rare, malignant neoplasm that is morphologically and immunophenotypically similar to its counterpart in salivary gland. It demonstrates myoepithelial differentiation, possessing both epithelial and myogenic characteristics. Thought to be chemotherapy insensitive, the optimal treatment regimen of this tumor has yet to be established and only a select few cases in the literature discuss treatment efficacy in detail. Here we present a case of a young adult with metastatic myoepithelial carcinoma with an initial excellent response to systemic therapy utilizing carboplatin and paclitaxel with continued complete response after 3 years. The patient also underwent complete surgical excision and received adjuvant radiation to the primary site of disease. Exome sequencing revealed an inactivating mutation in RB1 which we believe to be the first such mutation to be reported in this cancer type. Given increasing evidence suggesting RB1 loss is associated with responsiveness to conventional chemotherapies, particularly platinum-based regimens, we hypothesize that this genetic feature predisposed chemosensitivity in our patient’s tumor.